Snowball logo
logo
CLYY_logo

Celyad Oncology SA

$0.28$0.00  (0%)
Estimate
P/E
14
EPS
0.02
Beta
1.212
About the company
Ticker
CLYYF
ISIN
BE0974260896
Country
Belgium
Sector (GICS)
Healthcare
Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Frequently asked questions

What sector does Celyad Oncology SA (CLYYF) operate in?

Celyad Oncology SA belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Celyad Oncology SA (CLYYF) current stock price?

As of the latest data, Celyad Oncology SA stock price is $0.28, with a previous close of $0.28.

What is Celyad Oncology SA (CLYYF) current market capitalization?

Celyad Oncology SA market cap is approximately 12.53 million.

What is Celyad Oncology SA (CLYYF) Earnings Per Share (EPS)?

The trailing EPS is $0.02.

What is Celyad Oncology SA (CLYYF) Price-to-Earnings (P/E) ratio?

Celyad Oncology SA current P/E ratio is 14.

Does Celyad Oncology SA (CLYYF) pay dividends?

No. Celyad Oncology SA does not pay a dividend.

What is Celyad Oncology SA (CLYYF) beta (volatility) score?

Celyad Oncology SA has a beta of 1.212, suggesting it is more volatile than the market.